Walvax Biotechnology Hits Day Low of CNY 12.71 Amid Price Pressure

Walvax Biotechnology Co., Ltd. experienced a significant decline today, with its stock price dropping by 8.51% on July 17, 2026. The stock reached an intraday low of CNY 12.71, reflecting a challenging trading session for the company. In terms of performance metrics, Walvax's one-day performance contrasts sharply with the China Shanghai Composite, which fell by 3.05%. Over the past week, Walvax has seen a decrease of 2.59%, while the composite index declined by 5.81%. However, the company has shown resilience over the longer term, with a one-month increase of 6.58% compared to the composite's drop of 8.37%. Despite the recent downturn, Walvax has reported a year-to-date performance of 17.32%, significantly outperforming the composite index, which is down 5.16%. The company maintains a market capitalization of CNY 17,496 million and a price-to-earnings ratio of 69.00. With a return on equity of 3.40% and a price-to-book ratio of 2.36, Walvax continues to navigate a complex market landscape within the pharmaceuticals and biotechnology sector.